New combo tackles recurrent brain tumor: immunotherapy plus radiation before surgery
Disease control
Recruiting now
This early-phase trial is testing whether combining an immunotherapy drug (pembrolizumab) with targeted radiation before surgery is safe and feasible for people with recurrent glioblastoma, an aggressive brain cancer. Ten participants will receive the drug and radiation, then und…
Phase: PHASE1, PHASE2 • Sponsor: Chirag G. Patil • Aim: Disease control
Last updated Jun 26, 2026 12:36 UTC